Hemophilia drug from Sanofi and Sobi has license application accepted for priority review by FDA
The Biologics License Application (BLA) for Efanesoctocog alfa, a drug to treat the rare and…
August 30, 2022 - 2 minutes
Sobi
First Drug for Rare Inflammation Syndrome Approved by FDA
The FDA has approved the first drug for the treatment of a rare condition in…
November 22, 2018 - 2 minutes
Swedish Biotech Can Now Fast-Track its Metabolic Disorder Drug
Sobi will enter the clinic after the Investigational New Drug application for its rare metabolic…
January 23, 2018 - 2 minutes
Roche hits a Speed Bump on the way to a Hemophilia Cure
The Swiss pharma is gearing up for a battle with Novo Nordisk in Hemophilia, but…
November 4, 2016 - 4 minutes
Rare Disease Biopharma can now sell Hemophilia treatment across whole of EU
Sobi has received market approval by the European Comission for Alprolix, a long-duration protein therapy…
May 17, 2016 - 2 minutes
French Ipsen closes €700M deal for Californian Cancer Drug
Ipsen is paying Exelixis $200M upfront, plus $545M in future milestones to acquire commercialization rights…
March 1, 2016 - 2 minutes
Global Hemophilia AID project achieves first milestone with donations from Swedish Biotech
The Hemophilia Aid Program has just touched down the first batch of treatments in its…
October 13, 2015 - 3 minutes
What happened this week? Biotech revolutionizes Coffee, Paris N°1 Biocluster, a DNA-made Computer…
Welcome in our Top of the week list! This week is full of uncommon stories.…
August 22, 2015 - 2 minutes
